NLM Digital Collections

Search

Start Over Subjects Analgesics, Opioid -- adverse effects ✖Remove constraint Subjects: Analgesics, Opioid -- adverse effects

1. The opioid epidemic: national trends in opioid-related overdose deaths from 2000 to 2016

Author(s):
Planalp, Colin, author
Lahr, Megan, author
Publication:
[Minneapolis, Minnesota] : State Health Access Data Assistance Center, University of Minnesota, June 2018
Subject(s):
Drug Overdose -- epidemiology
Mortality -- trends
Opioid-Related Disorders -- epidemiology
Opioid-Related Disorders -- mortality
Analgesics, Opioid -- adverse effects
Adult
Aged
Continental Population Groups
Heroin -- adverse effects
Middle Aged
Sex Factors
Urban Population
Humans
United States

2. The opioid epidemic: state trends in opioid-related overdose deaths from 2000 to 2016

Author(s):
Planalp, Colin, author
Lahr, Megan, author
Publication:
[Minneapolis, Minnesota] : State Health Access Data Assistance Center, University of Minnesota, June 2018
Subject(s):
Drug Overdose -- mortality
Mortality -- trends
Opioid-Related Disorders -- epidemiology
Opioid-Related Disorders -- mortality
State Government
Analgesics, Opioid -- adverse effects
Heroin -- adverse effects
Prescription Drug Misuse
Humans
United States

3. Results of the opioid knowledge assessment from the PA Hospital Engagement Network adverse drug event collaboration

Publication:
[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2013
Subject(s):
Analgesics, Opioid -- therapeutic use
Community Networks
Cooperative Behavior
Health Knowledge, Attitudes, Practice
Interinstitutional Relations
Analgesics, Opioid -- adverse effects
Medication Errors -- prevention & control
Pain -- drug therapy
Humans
Pennsylvania
United States
Centers for Medicare & Medicaid Services (U.S.)

4. Results of the PA-HEN organization assessment of safe practices for a class of high-alert medications

Author(s):
Grissinger, Matthew, author
Lamis, Rebecca L., author
Publication:
[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, [2013]
Subject(s):
Analgesics, Opioid -- therapeutic use
Medical Order Entry Systems
Medication Errors -- prevention & control
Patient Care Team
Patient safety
Analgesia, Patient-Controlled
Analgesics, Opioid -- adverse effects
Monitoring, Physiologic
Nursing Assessment
Pain Measurement
Practice Guidelines as Topic -- standards
Risk Assessment
Humans
Pennsylvania
United States

5. Results of the 2013-2014 opioid knowledge assessment: progress seen, but room for improvement

Author(s):
Gaunt, Michael J., author
Alghamdi, Dalia, author
Grissinger, Matthew, author
Publication:
[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, September 2014
Subject(s):
Analgesics, Opioid -- therapeutic use
Analgesics, Opioid -- adverse effects
Clinical Competence -- statistics & numerical data
Health Knowledge, Attitudes, Practice
Pain Management -- standards
Personnel, Hospital -- education
Drug Tolerance
Hydromorphone -- adverse effects
Hydromorphone -- therapeutic use
Medication Errors -- prevention & control
Pain -- drug therapy
Patient safety
Morphine -- adverse effects
Morphine -- therapeutic use
Humans
Pennsylvania
United States

6. Management of patients with opioid dependence: a review of clinical, delivery system, and policy options

Publication:
[Boston, MA] : Institute for Clinical and Economic Review, July 2014
Subject(s):
Analgesics, Opioid -- therapeutic use
Buprenorphine -- therapeutic use
Comparative Effectiveness Research
Delivery of Health Care
Health Policy
Methadone -- therapeutic use
Naloxone -- therapeutic use
Naltrexone -- therapeutic use
Opiate Substitution Treatment -- economics
Opioid-Related Disorders -- drug therapy
Opioid-Related Disorders -- economics
Opioid-Related Disorders -- rehabilitation
Analgesics, Opioid -- administration & dosage
Analgesics, Opioid -- adverse effects
Budgets
Cohort Studies
Cost-Benefit Analysis
Counseling
Criminal Law
Drug Combinations
Drug Costs
Health Services Accessibility
Insurance Coverage
Medicaid
Medicare
Patient Care Team
Patient-Centered Care
Practice Guidelines as Topic
Treatment Outcome
Humans
New England
United States

7. Prescription drug monitoring programs: evolution and evidence

Author(s):
Weiner, Janet, author
Bao, Yuhua, author
Meisel, Zachary, author
Publication:
Philadelphia, PA : Leonard Davis Institute of Health Economics, June 2017
Subject(s):
Analgesics, Opioid -- adverse effects
Analgesics, Opioid -- therapeutic use
Drug and Narcotic Control
Drug Overdose -- epidemiology
Government Programs
Inappropriate Prescribing -- prevention & control
Opioid-Related Disorders
Mandatory Programs
State Government
Humans
United States

8. Controversies in migraine management: a technology assessment : final report

Author(s):
Tice, Jeffrey A., author
Ollendorf, Daniel A., author
Weissberg, Jed, author
Shore, Karen K., author
Pearson, Steven D., author
Publication:
[Boston, MA] : Institute for Clinical and Economic Review, August 19, 2014
Subject(s):
Analgesics, Opioid -- therapeutic use
Botulinum Toxins, Type A -- therapeutic use
Emergency Medical Services
Magnetic Field Therapy
Migraine Disorders -- drug therapy
Migraine Disorders -- economics
Migraine Disorders -- prevention & control
Migraine Disorders -- therapy
Transcutaneous Electric Nerve Stimulation
Analgesics, Opioid -- adverse effects
Analgesics, Opioid -- economics
Chronic Disease
Cost-Benefit Analysis
Disease Management
Insurance Coverage
Migraine Disorders -- epidemiology
Migraine with Aura -- therapy
Randomized Controlled Trials as Topic
Technology Assessment, Biomedical
Treatment Outcome
Humans
California
United States

9. Adverse drug events with HYDROmorphone: how preventable are they?

Publication:
[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2010
Subject(s):
Analgesics, Opioid -- adverse effects
Dose-Response Relationship, Drug
Hydromorphone -- adverse effects
Medication Errors -- prevention & control
Narcotics -- adverse effects
Analgesics, Opioid -- administration & dosage
Analgesics, Opioid -- pharmacology
Central Nervous System Diseases -- chemically induced
Clinical Protocols -- standards
Drug Administration Schedule
Drug Overdose -- epidemiology
Drug Prescriptions
Hydromorphone -- administration & dosage
Hydromorphone -- pharmacology
Morphine -- administration & dosage
Narcotics -- administration & dosage
Narcotics -- pharmacology
Pain Management
Receptors, Opioid, mu -- agonists
Respiration Disorders -- chemically induced
Risk Management
Humans
United States

10. Medication errors associated with documented allergies

Publication:
[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2008
Subject(s):
Drug Hypersensitivity -- prevention & control
Medication Errors
Analgesics, Opioid -- administration & dosage
Analgesics, Opioid -- adverse effects
Anti-Bacterial Agents -- administration & dosage
Anti-Bacterial Agents -- adverse effects
Communication
Documentation
Health Records, Personal
Risk Management
Humans
Pennsylvania
United States

12. Prescription opioids: Medicare should expand oversight efforts to reduce the risk of harm : testimony before the Subcommittee on Oversight, Committee on Ways and Means, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, January 17, 2018
Subject(s):
Drug and Narcotic Control
Inappropriate Prescribing -- prevention & control
Medicare Part D -- statistics & numerical data
Opioid-Related Disorders
Prescription Drug Misuse -- statistics & numerical data
Analgesics, Opioid -- adverse effects
Fraud -- prevention & control
Government Regulation
Inappropriate Prescribing -- statistics & numerical data
Medicare Part D -- economics
Humans
United States
Centers for Medicare & Medicaid Services (U.S.)

13. Making patient-controlled analgesia safer for patients

Publication:
[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2011
Subject(s):
Analgesia, Patient-Controlled -- instrumentation
Analgesics, Opioid -- administration & dosage
Medication Errors -- prevention & control
Analgesia, Patient-Controlled -- adverse effects
Analgesics, Opioid -- adverse effects
Equipment Safety
Infusion Pumps
Respiratory Insufficiency -- chemically induced
Humans
Pennsylvania
United States

14. Analysis of the multiple risks involving the use of IV fentaNYL

Publication:
[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2012
Subject(s):
Analgesics, Opioid -- administration & dosage
Analgesics, Opioid -- adverse effects
Analgesics, Opioid -- therapeutic use
Anesthetics, Intravenous -- administration & dosage
Anesthetics, Intravenous -- adverse effects
Anesthetics, Intravenous -- therapeutic use
Fentanyl -- administration & dosage
Fentanyl -- adverse effects
Fentanyl -- therapeutic use
Medication Errors -- prevention & control
Analgesia, Patient-Controlled
Infusions, Intravenous -- adverse effects
Pain Management -- methods
Risk Assessment
Humans
Pennsylvania
United States

15. The opioid epidemic: national trends in opioid-related overdose deaths from 2000 to 2017

Author(s):
Planalp, Colin, author
Hest, Robert, author
Lahr, Megan, author
Publication:
[Minneapolis, Minnesota] : State Health Access Data Assistance Center, June 2019
Subject(s):
Analgesics, Opioid -- adverse effects
Drug Overdose -- mortality
Mortality -- trends
Opioid-Related Disorders -- mortality
Central Nervous System Stimulants -- adverse effects
Cocaine -- adverse effects
Continental Population Groups
Ethnic Groups
Fentanyl -- adverse effects
Forecasting
Heroin -- adverse effects
Rural Population
Sex Factors
Street Drugs -- adverse effects
Urban Population
Humans
United States

16. The opioid epidemic: state trends in opioid-related overdose deaths from 2000 to 2017

Author(s):
Hest, Robert, author
Planalp, Colin, author
Lahr, Megan, author
Publication:
[Minneapolis, Minnesota] : State Health Access Data Assistance Center, June 2019
Subject(s):
Analgesics, Opioid -- adverse effects
Drug Overdose -- mortality
Mortality -- trends
Opioid-Related Disorders -- mortality
Central Nervous System Stimulants -- adverse effects
Cocaine -- adverse effects
Fentanyl -- adverse effects
Forecasting
Heroin -- adverse effects
Oxycodone -- adverse effects
State Government
Street Drugs -- adverse effects
Humans
United States